Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III open-label study of Begrivac 2006/2007 influenza vaccine in non-elderly and elderly adults
2006-000438-11Phase 3Completed
- Sponsor
- Chiron Behring Vaccines
- Start
- Apr 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Agrippal S1 in influenza, sponsored by Chiron Behring Vaccines. Primary endpoints: Immunogenicity with respect to specific antibody titers to each influenza strain and Safety of a single intramuscular dose of Begrivac. Started Apr 2006; status: completed.
02
Drugs
Agrippal S1
03
Conditions
influenza
Beyond the preview
Go deeper on 2006-000438-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000438-11.